These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38104275)

  • 41. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.
    Adamo FM; De Falco F; Dorillo E; Sorcini D; Stella A; Esposito A; Arcaleni R; Rosati E; Sportoletti P
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantum rods as nanocarriers of gene therapy.
    Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Law WC; Mahajan SD; Prasad PN; Schwartz SA
    Drug Deliv; 2012 May; 19(4):220-31. PubMed ID: 22643056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in siRNA delivery in cancer therapy.
    Singh A; Trivedi P; Jain NK
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivering the power of nanomedicine to patients today.
    Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R
    J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologics, theranostics, and personalized medicine in drug delivery systems.
    Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
    Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanomedicine approaches in acute lymphoblastic leukemia.
    Tatar AS; Nagy-Simon T; Tomuleasa C; Boca S; Astilean S
    J Control Release; 2016 Sep; 238():123-138. PubMed ID: 27460684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-assembled lipid nanomedicines for siRNA tumor targeting.
    Tseng YC; Huang L
    J Biomed Nanotechnol; 2009 Aug; 5(4):351-63. PubMed ID: 20055081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanovector delivery of siRNA for cancer therapy.
    Shen H; Sun T; Ferrari M
    Cancer Gene Ther; 2012 Jun; 19(6):367-73. PubMed ID: 22555511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanotechnology platforms; an innovative approach to brain tumor therapy.
    Nair BG; Varghese SH; Nair R; Yoshida Y; Maekawa T; Kumar DS
    Med Chem; 2011 Sep; 7(5):488-503. PubMed ID: 21801148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
    Eifler AC; Thaxton CS
    Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.
    Nawaz W; Xu S; Li Y; Huang B; Wu X; Wu Z
    Acta Biomater; 2020 Jun; 109():21-36. PubMed ID: 32294554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
    Hu DH; Gong P; Ma YF; Cai LT
    Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging Applications of Nanotechnology in Drug Delivery and Medical Imaging: Review.
    Singh S; Sharma H
    Curr Radiopharm; 2023; 16(4):269-283. PubMed ID: 37345242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.